Hypertension Drugs Tied To Higher Cancer Risk

Law360, New York (June 14, 2010, 6:52 PM EDT) -- Hypertension drugs including telmisartan, sold by Boehringer Ingelheim GmbH under the brand name Micardis, have been linked to an increased risk of cancer, according to a study published Monday.

The study, published online in The Lancet Oncology journal, looked at angiotensin-receptor blockers, a widely used drug class used to treat hypertension, heart failure, diabetic nephropathy, and to reduce cardiovascular risk.

To assess whether ARBs are linked to cancer, researchers from Case Western Reserve University in Cleveland looked through clinical trials published before November that included any...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.